Literature DB >> 17193204

Synthesis and biological evaluation of novel compounds related to 1-arylnaphthalene lignans and isoquinolines.

Hongxia Ding1, Wei Lu, Haibo Li, Leixiang Yang, Qijun Zhang, Changxin Zhou, Xiumei Wu, Olivier Baudoin, Junchao Cai, Françoise Guéritte, Yu Zhao.   

Abstract

Novel compounds designed as hybrids of 1-arylnaphthalene lignans with isoquinoline alkaloids were prepared and evaluated for their cytotoxicities on human tumor cell lines, such as A549, Hela, PC-3, CNE, BEL-7404, and KB. Some of the synthetic compounds exhibited their IC50 values on selected cell lines at 10(-6) M scale. The preliminary CoMFA molecular-modelling studies of these synthetic analogues were also performed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 17193204     DOI: 10.1002/cbdv.200590092

Source DB:  PubMed          Journal:  Chem Biodivers        ISSN: 1612-1872            Impact factor:   2.408


  5 in total

Review 1.  Engineering mesoporous silica nanoparticles for drug delivery: where are we after two decades?

Authors:  María Vallet-Regí; Ferdi Schüth; Daniel Lozano; Montserrat Colilla; Miguel Manzano
Journal:  Chem Soc Rev       Date:  2022-07-04       Impact factor: 60.615

Review 2.  Soft-template-assisted synthesis: a promising approach for the fabrication of transition metal oxides.

Authors:  Rasha Rahman Poolakkandy; Mini Mol Menamparambath
Journal:  Nanoscale Adv       Date:  2020-10-02

Review 3.  State-of-the-art developments in carbon-based metal nanocomposites as a catalyst: photocatalysis.

Authors:  Mohammad Ehtisham Khan
Journal:  Nanoscale Adv       Date:  2021-03-02

4.  3D defective graphenes with subnanometric porosity obtained by soft-templating following zeolite procedures.

Authors:  Lu Peng; Antonio Doménech-Carbó; Ana Primo; Hermenegildo García
Journal:  Nanoscale Adv       Date:  2019-10-21

Review 5.  Synthesis and applications of nanoporous perovskite metal oxides.

Authors:  Xiubing Huang; Guixia Zhao; Ge Wang; John T S Irvine
Journal:  Chem Sci       Date:  2018-04-02       Impact factor: 9.825

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.